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for a reason unknown to the patient.
Physical exam revealed the left lower extremity with +1 pedal and
ankle edema, and trace lower leg edema. Right leg was normal, with no
calf tenderness bilaterally. Pelvic exam revealed a ﬁrm cervix with no
gross lesions, upper one third of vagina was ﬁrm, indurated nearly
circumferentially. Left parametria was ﬁrm and 12 cm uterus ﬁxed to
left sidewall. Her initial work up was negative for lower extremity deepcervix and lower uterine segment, bilateral obstructive hydronephrosis
1. Introduction
Primary non-Hodgkin lymphoma (NHL) of the genital tract is a rare
ﬁnding accounting for less than 1% of all extra-nodal disease, with that
of the cervix accounting for 0.2–0.6% (Chan et al., 2005). Most patients
present at a mean age of 46 with vaginal bleeding, a large, bulky cervix
on exam, and without the common B symptoms of lymphoma. Cervical
cytology is not always helpful as the disease originates from the cervical
stroma (Chan et al., 2005). Approximately 70% are diagnosed at Ann
Arbor stage I, 22% at stage II, and 8% stage III and above. To date, approx-
imately 120 cases of primary extra-nodal cervical lymphoma have been
reported. Diffuse large B-cell lymphoma (DLBCL) subtype is most
commonly found at a rate of 30% (Anagnostopoulos et al., 2013). We
describe an interesting case by virtue of the unique presentation of
this disease and the extent of pelvic organ involvement.2. Case
A 22 year old G1P1 Hispanic female presented with complaints of
left lower extremity edema and rapidly increased abdominal girth
with pelvic pain over the past two months. She reported a history of
normal menses, except for the most recent which was prolonged. She
had no history of abnormal pap smears. Obstetrical history noted a
single spontaneous vaginal delivery at term in 2012. Her medical and
surgical history was signiﬁcant for the report of two negative lymphhia, PA 19147, USA. Fax:+1215
ss article under the CC BY-NC-ND licevenous thrombosis. Presenting laboratory values showed a white blood
count 9.7 × 103/mm3, hemoglobin 10.5 g/dL, platelets 232 × 103/mm3,
and a creatinine of 5.26 mg/dL.
A pelvic CT scan without contrast revealedmarked thickening of the
and hydroureter, with circumferential thickening of the bladder and
inﬂammatory changes in the left inguinal and femoral region of the
left upper thigh. Nuclear renal scan revealed complete absence of left
kidney function.
A percutaneous nephrostomy tube was placed in the right kidney to
treat the obstruction. An endometrial biopsy and pap smear were also
performed and noted secretory endometrium and atypical squamous
cells of undetermined signiﬁcance, human papilloma virus negative,
respectively. Colposcopy revealed no lesions and two biopsies of the
transformation zone and ECC displayed no evidence of malignancy.
Once her creatinine normalized an MRI with contrast was obtained,
revealing a large mass involving the posterior portion of the cervix ex-
tending upward toward the body of the uterus for a distance of 6.1 cm
and measured 4.1 cm in transverse dimension demonstrating a slight
increase in T2 signal with minimal enhancement. The mass extended
laterally to the pelvic sidewall, posteriorly into the presacral space and
inferiorly making it contiguous with the left lateral wall of the rectum.
Bulky left internal iliac adenopathy was also present (Fig. 1).
An exam under anesthesia with loop electrosurgical excisional pro-
cedure and vaginal biopsies was performed. Histology revealed diffuse
inﬁltration by large neoplastic lymphocytes. Immunostaining was dif-
fusely positive for pan B-cell markers CD20 and PAX5 with lymphoma
cells showing an activated B-cell immunophenotype (CD10 negative;
BCL6 and MUM1 positive) using the Hans algorithm. The proliferation
index as determined by Ki67 staining was estimated to be 70–80%
(Figs. 2, 3). These ﬁndings led to the diagnosis of DLBCL.
PET scan displayed FDG activity in the known pelvic mass as well as
posterior direct extension into the adjacent rectal wall. Nodal masses
were noted lateral to the left side of uterine body and right internal
iliac. Bonemarrowbiopsywas performed, but specimenwas insufﬁcient
for accurate evaluation, staging her lymphoma at IIE. The patient started
chemotherapy within a few weeks of diagnosis. Treatment consisted ofnse (http://creativecommons.org/licenses/by-nc-nd/3.0/).
Fig. 1.MRI image of large bulky cervixwith posteriormass contiguouswithwall of rectum.
2 E. Igwe et al. / Gynecologic Oncology Reports 10 (2014) 1–4rituximab, cyclophosphamide, hydroxydaunomycin, Oncovin and pred-
nisone (R-CHOP).
Due to the concern of rectal involvement a gastroenterologyworkup
was initiated. A lower endoscopic ultrasound revealed a hypoechoicFig. 2. Diffuse large B-cell lymphoma of the cervix. A. Diffuse inﬁltration by the tumor cells (H
staining for CD20 (H&E, 400×). D. Strongly positive PAX5 staining (H&E, 200×).mass in the anterior perirectal space. Sonographic evidence suggested
invasion into the muscularis propria between 12 and 18 cm from the
anal verge. Diagnostic laparoscopy was performed with the intent of
performing a diverting colostomy, but due to difﬁculty mobilizing the
descending colon secondary to dense adhesions, a loop ileostomy was
performed in order to provide prophylaxis against possible bowel perfo-
ration at chemotherapy induction.
Our patient is still undergoing chemotherapy, but has had signiﬁcant
delays in timing of treatments due to numerous hospital admissions for
neutropenic fever, pain, and urinary infections. A CT scan during a hos-
pitalization, approximately 3 months after her diagnosis and third cycle
of R-CHOP showed signiﬁcant response as judged by the size and homo-
geneity of the uterus and cervix. To date she has received 5 of 6 total cy-
cles of R-CHOP. PET/CT after cycle 5 showed no evidence of residual
metabolically active tumor in the abdomen or pelvis and no sites of
FDG activity to suggest recurrence of nodal or extranodal lymphoma.
There is no current plan for radiation treatment.3. Discussion
This case is very unique and challenging due to its rarity, metastatic
location andpatient age. Only one case of DLBCL of the cervix presenting
with bilateral hydronephrosis in an 82 year old exists in the literature
and with no mention of direct rectal invasion (Novotny et al., 2011).
This patient is the youngest documented to be affected by the disease
(Anagnostopoulos et al., 2013).
The diagnostic challenge is revealed by the similar presentation to
squamous cell carcinoma of the cervix with vaginal bleeding, ﬁxed, en-
larged uterus and cervix as well as possible parametrial inﬁltration
(Durson et al., 2005). It is very important to differentiate the etiology
of the tumor as treatment options are very different between squamous
cell/adenocarcinomaof the cervix versus B cell lymphoma, as surgery and&E, 40×). B. Tumor cells with large vesicular nuclei (H&E, 400×). C. Diffuse membranous
Fig. 3.Diffuse large B-cell lymphoma. A. Proliferation index of 70–80% (H&E, 200×). B. Negative CD10 staining (H&E, 200×). C. Positive BCL6 staining (H&E, 400×). D. PositiveMUM1 stain-
ing sssH&E, 200×).
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and at times radiation are of the latter. Cervical lymphoma is differentiat-
ed by its lack of involvement of squamous epithelium, therefore making
cytology smears generally non-diagnostic. This malignancy arises from
the cervical stroma (Anagnostopoulos et al., 2013), andgenerally requires
a deep cervical biopsy for diagnosis. Histopathologic evaluation must be
carried out for deﬁnitive diagnosis of speciﬁc cell type of lymphoma, as
was done in our patient.
Given the rare nature of cervical lymphoma, there is no consensus
regarding management and all therapies have been extrapolated
from other types of non-gynecologic lymphoma. Successful treat-
ments have been reported with the regimen of cyclophosphamide,
hydroxydaunomycin, Oncovin and prednisone (CHOP), new immu-
notherapy rituximab in addition to CHOP (R-CHOP), radiation and sur-
gery. Rituximab, a chimeric monoclonal antibody directed against the
CD20 antigen on B-cells, in addition to CHOP has shown, in numerous
randomized control trials, to have better overall survival than CHOP
alone for non-gynecologic DLBCL (Coifﬁer et al., 2002). Looking at treat-
ment options speciﬁcally for cervical lymphoma, the largest review of
cases to date, consisting of 118, showed that 9.2% had surgery only,
16.8% had chemotherapy only, 10.9% had radiotherapy only and the
remaining had multi-modal treatment. Rituximab was utilized in
11.7% of cases. No evidence of recurrencewas found in 85.2% of patients
at a mean follow-up of 40.5 months, with 10 patients died from their
disease within 40 months (Anagnostopoulos et al., 2013). Although
there is no gold standard for treatment, most treatments involve
chemotherapy and have led to acceptable survival data.
Another interesting challenge in our patient is her rectal involvement.
The majority of colorectal NHL is secondary to metastasis, with the rec-
tum being a common site (Ghimire et al., 2011). It was decided that our
patient would beneﬁt from bowel diversion due to the rare but possible
risk of tumor necrosis causing intestinal perforation after chemotherapy
induction (Vaidya et al., 2013). There is no consensus whether surgery
is indicated in all cases. One investigator reported better outcomes withsurgical resection of lymphomas followed by chemotherapy. Important
factors in the decision making process are the intestinal location, extent
of disease and pace of disease progression (Zinzani et al., 1997). Our
patient's invasive perirectal mass and tumor burden made laparoscopic
mobilization of the descending colon at the time of colostomy difﬁcult,
so an ileostomy was performed to gain the beneﬁt of diversion while
remaining minimally invasive with less morbidity.
Since most cases of this disease are found at a mean age of 46, the
consideration of future fertility in this 22 year old primipara was very
important. There are few reports in current literature, but successful
pregnancies have occurred after cervical lymphoma treatment with
CHOP, R-CHOP or CHOP and cold knife cone. These women presented
in their late twenties and became pregnant within 20 and 72 months,
having uncomplicated full-term deliveries (Parva et al., 2011; Lorusso
et al., 2007). With our patient's current treatment regimen of immuno/
chemotherapy her fertility is preserved for possible future childbearing.
Although primary cervical lymphoma is a very rare diagnosis, it is im-
portant to be on the differential diagnosis as treatment generally leads to
a better prognosis than other advanced gynecologic malignancies.Conﬂict of interest statement
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